secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sintx Technologies, Inc. (SINT)
CIK:        0001269026
Form:       8-K
Filed at:   2026-08-11T20:10:37+00:00
Accession:  0001493152-26-037130
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SINTX guides Q3-Q4 2026 revenue of $0.9M-$1.3M per quarter; $3.2M industrial orders
--------------------------------------------------------------------------------

- Q3 2026 revenue guided to $0.9M-$1.1M; Q4 2026 to $1.0M-$1.3M, subject to delivery and customer acceptance.
- Received ~$3.2M in H1 2026 industrial purchase orders from contract manufacturers; revenue recognition expected from Q3 2026.
- SiNAPTIC Foot & Ankle Wedge System (FDA 510(k) cleared Oct 2025) in Limited Use Release; 12 independent orthopedic distributors engaged.
- Q2 2026 financing raised ~$5.0M gross via private placement and ATM facility to fund commercialization and operations.
- NIH granted 12-month extension to access ~$745K remaining on $1.97M grant for porous SiN/PEEK spinal implant development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1269026/000149315226037130/0001493152-26-037130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1269026/000149315226037130/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-037130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer